HSTOQ — Histogen Share News
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
- $0.01m
- -$5.60m
- $3.77m
U.S. STOCKS ON THE MOVE-United Airlines, AMC Entertainment, Rubius Therapeutics
U.S. STOCKS ON THE MOVE-Equillium, Histogen, AMC Entertainment
Brief: Histogen Announces Removal Of Clinical Hold By FDA For Hst-003 Ind To Initiate A Phase 1/2 Trial For Knee Cartilage Regeneration
Refile: BUZZ-Histogen: Jumps as FDA removes clinical hold on tissue defect treatment study
Brief: Histogen Reports Fourth Quarter And Year-End 2020 Financial Results And Provides Business Update
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:34 PM
Brief: Histogen Announces Week 26 HST-001 Study Results For The Treatment Of Androgenic Alopecia In Men
U.S. STOCKS ON THE MOVE-Netflix, Procter & Gamble, Disney, Gevo, BNY Mellon
U.S. STOCKS ON THE MOVE-Boeing, Netflix, Disney, Alibaba Group
U.S. STOCKS ON THE MOVE-Netflix, Morgan Stanley, Tesla, Disney, Roku
U.S. STOCKS ON THE MOVE-Netflix, Alibaba Group, Best, Histogen
Histogen: Down as FDA puts on hold tissue defect treatment study
Brief: Histogen Reports FDA Clinical Hold For Planned Phase 1/2 Trial Of HST-003
Brief: Histogen Files For Offering In Best-Efforts Offering Of 11.6 Million Shares
Brief: Histogen Announces Public Offering of 14 Mln Shares At $1 Per Share
Brief: Histogen Says Phase 1/2 Trial Initiation For Knee Cartilage Regeneration Anticipated In Q1 2021
Brief: Histogen Announces Preliminary Week 18 HST-001 Study Results for the Treatment of Androgenic Alopecia in Men
Brief: Histogen Announces $4.5 Mln Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Brief: Histogen Reports Qtrly Loss Per Share 27 Cents